SENSEX
NIFTY
GOLD
USD/INR

Weather

image 17    C

Economy News

The Economic Times

Economy / The Economic Times

details

AstraZeneca gets CDSCO approval for Durvalumab in gastric cancer treatment

AstraZeneca Pharma India has secured approval for Durvalumab. This drug, combined with chemotherapy, will treat gastric and gastroesophageal junction cancer. The approval comes from the Central Drugs Standard Control Organisation. This new treatment offers a perioperative immunotherapy approach for adult patients. It aims to improve survival rates for those with resectable forms of the disease.

4 Feb 2026 3:45 pm